Home > Products > CD16 & HER2
> Recombinant Anti-CD16 x Anti-HER2 VHH BispecificAntibody (IgG-VHH)
Recombinant Anti-CD16 x Anti-HER2 VHH BispecificAntibody (IgG-VHH) (CAT#: IGVHH-007)
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-VHH) is designed to be expressed as a LC and an extended HC with VHH moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-HER2 VHH BispecificAntibody (IgG-VHH) (IGVHH-007). Click the button below to contact us or submit your feedback about this product.